Terumo Cardiovascular’s Post

🎉 Happy Clinical Trials Day! 🎉 Today, we celebrate the invaluable contributions of clinical trials in advancing medical research and improving patient care. Clinical trials are the backbone of medical progress, paving the way for new treatments, medications, and therapies that save lives and enhance quality of life. From the meticulous planning to the dedicated participation of patients and the tireless efforts of researchers and healthcare professionals, clinical trials represent a collaborative journey towards innovation and better health outcomes. Each trial brings us closer to breakthroughs in understanding diseases, developing effective treatments, and ultimately, achieving healthier futures for all. As we commemorate Clinical Trials Day, let's acknowledge and express gratitude to everyone involved in this vital process – from volunteers and clinicians to sponsors and regulators. Your dedication and commitment to advancing medical science are truly inspiring. Let's continue to support and champion clinical research, recognizing its critical role in shaping the future of healthcare. Together, we can make a difference and bring hope to millions worldwide. 🌟 #ClinicalTrialsDay #MedicalResearch #HealthcareInnovation #PatientCare #ClinicalTrials #ResearchMatters

The latest report from Newmarket Strategy explores the challenges of engaging primary care in clinical research delivery and puts forward six recommendations for improvement. The under-recruitment of patients into clinical trials creates a significant barrier to translating basic science discoveries into medical practice, which has a direct knock-on impact on the treatment and quality of care that patients can receive. Primary care data could help to tackle this issue. The richness and continuity of the primary care records means that it can be easier to identify patients for clinical research than it would be using other methods. Our Recruit solution enables primary care professionals to easily identify and contact potentially eligible patients in their area to participate in clinical trials. Find out more on our website: https://okt.to/VMBjD4

Join us for our next #ClimedoConnect webinar on the challenges and needs of clinical trial physicians. On May 15 at 3pm CET, we’ll explore the topic of trial physician participation in clinical trials and what needs to change. We'll be joined by Professor Lothar Färber (former CSO of Novartis) to delve into this important issue and share exclusive insights from a recent survey conducted among 65+ European trial physicians by Climedo and Siteworks. Don't miss out on this valuable discussion! What to expect: ✅ Exclusive Insights: Access unique findings from our recent survey ✅ Interactive Polls: Share your thoughts in real-time ✅ Live Discussion: Engage with fellow industry experts to explore how they're addressing challenges and ask any question you may have Don't miss out on this opportunity and register now: https://lnkd.in/dSrJ3P-J #ClinicalTrials #TrialPhysicians #MedicalResearch

Figures from a new MTPConnect report reveal that Australia’s clinical trials sector generated $1.6 billion for the Australian economy in 2022. The outcome represents growth of more than 4% on 2019 and has been achieved despite the 2020 pandemic downturn. MTPConnect CEO, Stuart Dignam said, “Clinical trials are a critical step in the R&D pipeline for new treatments and as well as ensuring Australian patients receive the best, safest and most effective treatments, these new figures show clinical trials are more valuable for the economy than ever before.” The report highlights five emerging opportunities for consideration including patient engagement, digital health solutions, precision healthcare, innovative trial designs, and medical device trials. Learn more: https://loom.ly/sfLw7Ks

🌟 Are you ready to unlock the secrets behind evidence-based medicine? Dive into the world of randomized controlled trials (RCTs), the gold standard in clinical research! 🤔 Discover how RCTs shape treatment protocols and improve patient outcomes, benefits, and limitations. Click the link below to delve deeper into RCTs in our latest blog post! #RCTs #ClinicalResearch #ClinicalTrials #TrialDesign #ClinicaltrialSolutions 📚https://lnkd.in/gFquue6H

📑Bridging patient and physician gaps in clinical trials. In clinical research, understanding the perspectives of both patients and physicians is essential for improving trial experiences. For this reason, Climedo recently embarked on two comprehensive surveys to gather valuable insights from these stakeholders. Climedo’s latest Whitepaper explores various aspects of clinical trials, including motivation for participation, barriers and challenges faced during trial participation, use of digital tools and stakeholder expectations from other participants. ⬇️ Download your free copy here: https://lnkd.in/dVtpu-si

🌍✨ **Celebrating International Clinical Trials Day!** ✨🌍 Today, we honor the incredible innovation and dedication behind clinical trials. These trials are the cornerstone of medical breakthroughs, reimagining medicine to bring hope and healing to patients worldwide. 🔬 **Innovation in Action:** Clinical trials fuel the development of new treatments, therapies, and cures, ensuring that every patient receives the best possible care. Each trial is a step towards a healthier, brighter future. ❤️ **Patient-Centric:** At the heart of every clinical trial are the patients. Their courage and participation drive progress and bring life-saving solutions to those in need. Join us in celebrating the researchers, healthcare professionals, and especially the patients who make clinical trials possible. Together, we are shaping the future of medicine, one trial at a time. #ICTD2024 #MedicalInnovation #PatientsFirst #ReimaginingMedicine #HopeInResearch

The latest report from Newmarket Strategy explores the challenges of engaging primary care in clinical research delivery and puts forward six recommendations for improvement. The under-recruitment of patients into clinical trials creates a significant barrier to translating basic science discoveries into medical practice, which has a direct knock-on impact on the treatment and quality of care that patients can receive. Primary care data could help to tackle this issue. The richness and continuity of the primary care records means that it can be easier to identify patients for clinical research than it would be using other methods. Our Recruit solution enables primary care professionals to easily identify and contact potentially eligible patients in their area to participate in clinical trials. Find out more on our website: https://okt.to/GiHlDj

Pharmacogenomics is a big part of medication safety and optimizing your med list. Dr. Lusia Fomuso PharmD, MPH, CPGX loves collaborating with physicians, healthcare professionals, and patients to leverage pharmacogenomics to optimize medications. Listen to learn more about this important topic and about Dr. Lusia Fomoso's books including Pharmacogenomics Basics.

The clinical trial industry is constantly evolving. Staying on top of these changes is important to set your trials up for success in the future, especially with regards to personalized medicine, patient-centric trials and more. In a PharmaTimes Media Ltd article, Graham Belgrave talks about the latest changes happening in the clinical trial industry and how we can embrace this change. Read the article: https://hubs.la/Q02ssxCw0 #ClinicalTrials #ClinicalResearch #ABetterClinicalExperience